Skip NavigationFMCSA Home U.S. Department of Transportation Contact NRCME  

National Registry of Certified Medical Examiners

Federal Motor Carrier Safety Administration

Home About Meetings & Conferences Training & Certification Medical Examiners CMV Drivers & Motor Carriers Rules & Regulations
 

Guidance/Advisory Criteria — Conditions

Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy is a complex disease characterized by marked morphologic, genetic, and prognostic heterogeneity. Some individuals experience a benign and stable clinical course, while in others the disease is characterized by progressive symptoms. For some individuals, sudden death is the first definitive manifestation of the disease.

Certification/Recertification — Hypertrophic Cardiomyopathy

Waiting period

If you note an enlarged heart in a driver, you should not certify the driver until evaluation by a cardiovascular specialist who understands the functions and demands of commercial driving to confirm or rule out a diagnosis of hypertrophic cardiomyopathy.

Decision

Recommend to certify if:

Not applicable.

Recommend not to certify if:

The driver has a diagnosis of hypertrophic cardiomyopathy.

Monitoring/Testing

Not applicable.

Follow-up

Not applicable.

Cardiomyopathies and Congestive Heart Failure Recommendation Table (PDF)

Go To Top of Page